There is also the broader context of platform ecosystems, where integration, fairness audits, and promotions influence perception
When Results Plateau In community-reported reta+cagri protocols, plateaus are commonly reported at: Month 68 for users who hold retatrutide at 2 mg/week typically resolves by titrating retatrutide to 3 mg or holding while cagrilintide finishes ramping to 2.4 mg Month 12+ for users at the community ceiling (reta 4 mg + cagri 2.4 mg) no additional dose lever within the conservative community protocol
Grundy MML, Fardet A, Tosh SM, Rich GT, Wilde PJ
Therefore, Its appetite and weight effects overlap functionally with GLP-1 therapies, but the primary receptor mechanism is different
True problems that require intervention typically become more obvious over time rather than resolving spontaneously
What are the side effects of Peaka GLP-1